2011 Proposals
Council I
Only those Proposals which were passed (either passed as submitted
or passed as amended) are shown here:
Council I Proposals
(Proposal 121 does not
show up in the Council I Proposals, you may get it here. - Proposal 121.)
The Proposals highlighted in green are
the ones to which editorial changes were made
at the request of FDA(none in 2011).
Proposal # | No Action | Passed as Submitted | Passed as Amended | Proposal # | No Action | Passed as Submitted | Passed as Amended | |
101 | X* | 125 | X | |||||
102 | X | 126 | X | |||||
103 | X | 127 | X* | |||||
104 | X | 128 | X* | |||||
105 | X | 129 | X | |||||
106 | X | 130 | X | |||||
107 | X | |||||||
108 | X | |||||||
109 | X | |||||||
110 | X | |||||||
111 | X | |||||||
112 | X | |||||||
113 | X | |||||||
114 | X* | |||||||
115 | X* | |||||||
116 | X* | |||||||
117 | X* | |||||||
118 | X | |||||||
119 | X | |||||||
120 | X* | |||||||
121 | X | |||||||
122 | X | |||||||
123 | X | |||||||
124 | X |
Council II
Only those Proposals which were passed (either passed as submitted
or passed as amended) are shown here:
Council II Proposals
! NOTE: In the August 29, 2011 letter to the Conference Chair John Miller, the FDA did not concur with Proposal 209. On October 5, 2011, the NCIMS Executive Board accepted the FDA non-concurrence and agreed to address the issue at the next conference.
The Proposals highlighted in green are the ones to which editorial changes were made
at the request of FDA (none in 2011).
Proposal # | No Action | Passed as Submitted | Passed as Amended | Proposal # | No Action | Passed as Submitted | Passed as Amended | |
201 | X | 225 | X** | |||||
202 | X | 226 | X** | |||||
203 | X | 227 | X** | |||||
204 | X | 228 | X** | |||||
205 | X | 229 | X** | |||||
206 | X | 230 | X** | |||||
207 | X | 231 | X** | |||||
208 | X | 232 | X** | |||||
209 | X ! | 233 | X** | |||||
210 | X | 234 | X** | |||||
211 | X | 235 | X | |||||
212 | X | 236 | X | |||||
213 | X | 237 | X | |||||
214 | X | 238 | X | |||||
215 | X | 239 | X | |||||
216 | X | 240 | X | |||||
217 | X | 241 | X | |||||
218 | X | 242 | X | |||||
219 | X** | 243 | X | |||||
220 | X | 244 | X | |||||
221 | X | 245 | X | |||||
222 | X | 246 | X | |||||
223 | X | 247 | X | |||||
224 | X** | 248 | X** |
**Passed to 2400 series form process
Council III
Only those Proposals which were passed (either passed as submitted
or passed as amended) are shown here:
Council III Proposals
Attachments to Proposal 301 are included here:
2011-301 Attachment 1 - Procedures, 2011-301 Attachment 2 - PMO, 2011-301 Attachment 3 - MMSR.
The Proposals
highlighted in green are the ones to which editorial changes were made
at the request of FDA (none in 2011).
Proposal # | No Action | Passed as Submitted | Passed as Amended | Proposal # | No Action | Passed as Submitted | Passed as Amended | |
301 | X | 309 | X | |||||
302 | X | 310 | X | |||||
303 | X | 311 | X | |||||
304 | X | 312 | X | |||||
305 | X | 313 | X | |||||
306 | X | |||||||
307 | X | |||||||
308 | X |